**Exclusive - MHRA Launch Pilot Scheme to Push for More ADR's to be Reported.

fiddaman · 11-04-2009, 07:22 AM

As a long time critic of the MHRA's Yellow Card reporting system, credit where credit is due, I have to applaud their latest pilot scheme. I think it shows that the MHRA are aware that the Yellow Card system needs work and, it would appear, that they are actually doing something about it.

Back in October, they launched the scheme with the launch of video advertisements in doctors surgeries, and promotional activity to GPs and other primary care professionals at Primary Care Live (a big conference/exhibition in London).

Simon Gregor, MHRA Communications Director, told me, "The campaign is not in one specific area in the UK, but we are working with particular groups of surgeries. For the leaflets, we are working with those surgeries which use something called the IDS leaflet system, which is a means of getting the YC leaflets into the surgeries. There are 6000 surgeries which use this system, and we are aiming to distribute leaflets through all of them."

He added, "For the video, we are using a service called the Life Channel, which has a presence in 400 GP surgeries."

Some of the key points of this scheme are thus:

READ MORE

**Don't forget to vote in the Seroxat withdrawal poll [right hand side of blog]

jeremy9282 · 11-05-2009, 12:30 AM

Yellow Card scheme pilot launch, 25th October 2005

http://www.pals.nhs.uk/CmsContentView.aspx?ItemId=1001

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Committee on Safety of Medicines (CSM) launch the UK-wide pilot to enable patient reporting of suspected side effects.

•Author: PALS Online
•E-mail to a friend:
•Reference: 1001
•Last updated: 23 Oct 2005 20:10
•Print:

The pilot will build on the encouraging response from patients and members of the public to initial patient reporting pilots that have been running since January. The insight and experience gained through these initial pilots, together with consultation with patients and members of the public, has facilitated the development of a UK-wide patient reporting pilot.

The pilot will make patient Yellow Card forms available at a wide range of outlets across the NHS, including community pharmacies, GP surgeries and at Patient Advice and Liaison Centres and Offices. Reporting via the web on the Yellow Card website (at www.yellowcard.gov.uk) and to the freephone Yellow Card hotline will also be piloted.

Through the course of the development of pilots for patient reporting, the MHRA and the CSM, the Government's independent scientific committee on medicines safety, have been advised by the CSM's Working Group on Patient Reporting. The Working Group have focused on the development of patient reporting mechanisms that are easy to use and access, while providing the information needed to monitor effectively the safety of medicines.

Patient reporting through the Yellow Card Scheme represents a significant step forward in involving patients and members of the public in medicines safety monitoring. The Yellow Card Scheme is vital for protecting public health, and the MHRA and CSM welcome reports on the whole range of medicines, including prescribed medicines, over the counter medicines and complementary remedies (including herbal remedies). There are many reasons why receiving Yellow Card reports from patients is important, but particularly to better understand the patient's view and experience of suspected side effects

jeremy9282 · 11-05-2009, 12:34 AM

What ever happened to the earlier (Oct 2005) Yellow Card Pilot?

http://www.pals.nhs.uk/CmsContentView.aspx?ItemId=1001

What difference did it make to the safety of patients?

Is the MHRA just simply launching pilots for the sake of appearing to do something?

Is it all window dressing?

Could the MHRA be taking mental health patients for a ride in the consultation process?

Regards Jeremy

Could Simon Gregor of the MHRA be exploiting victims of pharma companies in a cynical manipulation to make themselves look clean?

jeremy9282 · 11-05-2009, 12:41 AM

RPSGB Welcomes Yellow Card Scheme, a UK-Wide Pilot for Patients

http://www.prnewswire.co.uk/cgi/news/release?id=156751

LONDON, October 25 /PRNewswire/ -- The Royal Pharmaceutical Society of Great Britain (RPSGB) welcomes the launch today by the Medicines and Healthcare Products Regulatory Agency (MHRA) of a UK-wide pilot to enable patients to report suspected adverse drug reaction (ADR) experiences through the Yellow Card Scheme.

Commenting on the importance of the Yellow Card Scheme, Rob Darracott, Director of Corporate & Strategic Development at the RPSGB, says:

"The RPSGB has long championed the importance of medicines safety and the role of pharmacists in educating the public about medicines and their use. Pharmacists are ideally placed to engage with members of the public about the affects of their medicines and if appropriate to encourage them to make their own Yellow Card Scheme reports."

Reports can be made by health professionals and patients on the Yellow Card website at www.yellowcard.gov.uk.

Distributed by PR Newswire on behalf of The Royal Pharmaceutical Society of Great Britain

--------------------------------------------------------------------------------
PR Newswire Europe Ltd.

209 - 215 Blackfriars Road, London, SE1 8NL
Tel : +44 (0)20 7490 8111
Fax : +44 (0)20 7490 1255
E-mail : info@prnewswire.co.uk

Copyright © 2009 PR Newswire Europe Limited. All rights reserved.
A United Business Media Company.
Terms and conditions of use apply.

11-04-2009, 07:22 AM	#1
fiddaman Join Date: Jan 2007 Location: Birmingham, UK Posts: 292	Exclusive - MHRA Launch Pilot Scheme to Push for More ADR's to be Reported. As a long time critic of the MHRA's Yellow Card reporting system, credit where credit is due, I have to applaud their latest pilot scheme. I think it shows that the MHRA are aware that the Yellow Card system needs work and, it would appear, that they are actually doing something about it. Back in October, they launched the scheme with the launch of video advertisements in doctors surgeries, and promotional activity to GPs and other primary care professionals at Primary Care Live (a big conference/exhibition in London). Simon Gregor, MHRA Communications Director, told me, "The campaign is not in one specific area in the UK, but we are working with particular groups of surgeries. For the leaflets, we are working with those surgeries which use something called the IDS leaflet system, which is a means of getting the YC leaflets into the surgeries. There are 6000 surgeries which use this system, and we are aiming to distribute leaflets through all of them." He added, "For the video, we are using a service called the Life Channel, which has a presence in 400 GP surgeries." Some of the key points of this scheme are thus: READ MORE Don't forget to vote in the Seroxat withdrawal poll [right hand side of blog] __________________ Fid http://fiddaman.blogspot.com I think patients have nothing to fear from taking Seroxat. Dr. Alastair Benbow, GlaxoSmithKline’s European Medical Director 6/13/2002

11-05-2009, 12:30 AM	#2
jeremy9282 Join Date: Jul 2009 Posts: 105	Yellow Card scheme (patients) pilot launch, 25th October 2005 *Yellow Card scheme pilot launch, 25th October 2005* http://www.pals.nhs.uk/CmsContentView.aspx?ItemId=1001 The Medicines and Healthcare products Regulatory Agency (MHRA) and the Committee on Safety of Medicines (CSM) launch the UK-wide pilot to enable patient reporting of suspected side effects. •Author: PALS Online •E-mail to a friend: •Reference: 1001 •Last updated: 23 Oct 2005 20:10 •Print: The pilot will build on the encouraging response from patients and members of the public to initial patient reporting pilots that have been running since January. The insight and experience gained through these initial pilots, together with consultation with patients and members of the public, has facilitated the development of a UK-wide patient reporting pilot. The pilot will make patient Yellow Card forms available at a wide range of outlets across the NHS, including community pharmacies, GP surgeries and at Patient Advice and Liaison Centres and Offices. Reporting via the web on the Yellow Card website (at www.yellowcard.gov.uk) and to the freephone Yellow Card hotline will also be piloted. Through the course of the development of pilots for patient reporting, the MHRA and the CSM, the Government's independent scientific committee on medicines safety, have been advised by the CSM's Working Group on Patient Reporting. The Working Group have focused on the development of patient reporting mechanisms that are easy to use and access, while providing the information needed to monitor effectively the safety of medicines. Patient reporting through the Yellow Card Scheme represents a significant step forward in involving patients and members of the public in medicines safety monitoring. The Yellow Card Scheme is vital for protecting public health, and the MHRA and CSM welcome reports on the whole range of medicines, including prescribed medicines, over the counter medicines and complementary remedies (including herbal remedies). There are many reasons why receiving Yellow Card reports from patients is important, but particularly to better understand the patient's view and experience of suspected side effects

11-05-2009, 12:34 AM	#3
jeremy9282 Join Date: Jul 2009 Posts: 105	Re: Exclusive - MHRA Launch Pilot Scheme to Push for More ADR's to be Reported. What ever happened to the earlier (Oct 2005) Yellow Card Pilot? http://www.pals.nhs.uk/CmsContentView.aspx?ItemId=1001 What difference did it make to the safety of patients? Is the MHRA just simply launching pilots for the sake of appearing to do something? Is it all window dressing? Could the MHRA be taking mental health patients for a ride in the consultation process? Regards Jeremy Could Simon Gregor of the MHRA be exploiting victims of pharma companies in a cynical manipulation to make themselves look clean?**

11-05-2009, 12:41 AM	#4
jeremy9282 Join Date: Jul 2009 Posts: 105	Update - Earlier patients Yellow Card Scheme (Oct 2005) was a UK WIDE PILOT !! RPSGB Welcomes Yellow Card Scheme, a UK-Wide Pilot for Patients http://www.prnewswire.co.uk/cgi/news/release?id=156751 LONDON, October 25 /PRNewswire/ -- The Royal Pharmaceutical Society of Great Britain (RPSGB) welcomes the launch today by the Medicines and Healthcare Products Regulatory Agency (MHRA) of a UK-wide pilot to enable patients to report suspected adverse drug reaction (ADR) experiences through the Yellow Card Scheme. Commenting on the importance of the Yellow Card Scheme, Rob Darracott, Director of Corporate & Strategic Development at the RPSGB, says: "The RPSGB has long championed the importance of medicines safety and the role of pharmacists in educating the public about medicines and their use. Pharmacists are ideally placed to engage with members of the public about the affects of their medicines and if appropriate to encourage them to make their own Yellow Card Scheme reports." Reports can be made by health professionals and patients on the Yellow Card website at www.yellowcard.gov.uk. Distributed by PR Newswire on behalf of The Royal Pharmaceutical Society of Great Britain -------------------------------------------------------------------------------- PR Newswire Europe Ltd. 209 - 215 Blackfriars Road, London, SE1 8NL Tel : +44 (0)20 7490 8111 Fax : +44 (0)20 7490 1255 E-mail : info@prnewswire.co.uk Copyright © 2009 PR Newswire Europe Limited. All rights reserved. A United Business Media Company. Terms and conditions of use apply.

Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)